Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (321-330 of 628) with videos related to

Pageof 63
Sort By:
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshopAnneMarie W Block, Andrew J Carroll, Anne Hagemeijer, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotypingSheila N J Sait, Misbah U Qadir, Jeffrey M Conroy, et al.
Molecular Cancer Therapeutics|January 30, 2016
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentWilliam D Hedrich, Jingwei Xiao, Scott Heyward, et al.
Blood|July 1, 1989
The chromosome translocation (11;14)(p13;q11) associated with T-cell acute lymphocytic leukemia: an 11p13 breakpoint cluster regionG Yoffe, N Schneider, L Van Dyk, et al.
Cancer|August 8, 2013
Lenalidomide performance in the real world: patterns of use and effectiveness in a Medicare population with myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Diane L McNally, et al.
Cancer|November 7, 1998
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapyM Shah, E H Jenis, B K Mookerjee, et al.
Investigational New Drugs|January 20, 2015
The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrationsTrevor J Mathias, Karthika Natarajan, Suneet Shukla, et al.
Translational Oncology|November 22, 2021
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancersAnna J Dellomo, Rachel Abbotts, Christian L Eberly, et al.
The EMBO Journal|March 1, 1996
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic miceR C Larson, I Lavenir, T A Larson, et al.
Pageof 63

Showing results (321-330 of 628) with videos related to

Sort By:
Pageof 63
Oncogene|May 30, 2012
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemiasL A Tobin, C Robert, A P Rapoport, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshopAnneMarie W Block, Andrew J Carroll, Anne Hagemeijer, et al.
Genes, Chromosomes & Cancer|March 29, 2002
Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotypingSheila N J Sait, Misbah U Qadir, Jeffrey M Conroy, et al.
Molecular Cancer Therapeutics|January 30, 2016
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentWilliam D Hedrich, Jingwei Xiao, Scott Heyward, et al.
Blood|July 1, 1989
The chromosome translocation (11;14)(p13;q11) associated with T-cell acute lymphocytic leukemia: an 11p13 breakpoint cluster regionG Yoffe, N Schneider, L Van Dyk, et al.
Cancer|August 8, 2013
Lenalidomide performance in the real world: patterns of use and effectiveness in a Medicare population with myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Diane L McNally, et al.
Cancer|November 7, 1998
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapyM Shah, E H Jenis, B K Mookerjee, et al.
Investigational New Drugs|January 20, 2015
The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrationsTrevor J Mathias, Karthika Natarajan, Suneet Shukla, et al.
Translational Oncology|November 22, 2021
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancersAnna J Dellomo, Rachel Abbotts, Christian L Eberly, et al.
The EMBO Journal|March 1, 1996
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic miceR C Larson, I Lavenir, T A Larson, et al.
Pageof 63